drugset / Trial / NCT03665038
A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-center study evaluating the safety, tolerability, and pharmacokinetics of brexanolone in the treatment of adolescent female participants with postpartum depression (PPD).
Timeline
- Start
- 2018-09-07
- Primary completion
- 2021-01-08
- Completion
- 2021-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brexanolone | Unknown | 90 ug/kg | Intravenous |